These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. [Stimulators of beta-adrenergic structures in treatment of ischemic heart disease]. Komarov FI; Ol'binskaia LI; Abinder AA; Iankin VV; Kitaeva IT Kardiologiia; 1975 Jul; 15(7):37-43. PubMed ID: 1568 [TBL] [Abstract][Full Text] [Related]
2. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease]. At'kov OIu; Krol VA; Chumburidze VB Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937 [No Abstract] [Full Text] [Related]
3. [Use of beta-stimulators in chronic ischemic heart disease with complete atrioventricular block complicated by congestive circulatory insufficiency]. Kukes VG; Tsoi AN; Alkhazov AI; Sivkov SI Kardiologiia; 1976 Aug; 16(8):53-8. PubMed ID: 13236 [TBL] [Abstract][Full Text] [Related]
4. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease]. Komarov FI; Ol'binskaia LI; Bragina GI Ter Arkh; 1979; 51(8):13-7. PubMed ID: 41333 [No Abstract] [Full Text] [Related]
5. [Results of clinical studies of beta stimulating agents in the treatment of chronic heart disease]. Metelutsa VI; Chazova LV; Grigor'iants RA; Krol VA; Trubetskoĭ AV Ter Arkh; 1977; 49(4):44-8. PubMed ID: 17171 [No Abstract] [Full Text] [Related]
6. [Effect of blockaders of cardiac beta-adrenergic structures on the central hemodynamics and contractile function of the myocardium in acute experimental coronary insufficiency]. Ol'binskaia LI; Sandrikov VA; Ptashnikova TN; Sadovnikov VI; Trekova NA Kardiologiia; 1979 Sep; 19(9):100-3. PubMed ID: 40059 [TBL] [Abstract][Full Text] [Related]
7. [Effect of adrenergic beta blockers on hemodynamics, diastolic relaxation and distensibility of left-ventricular myocardium in patients with ischemic heart disease]. Moroz VA; Gladchenko AR; Latoguz IK; Khimenko PL Klin Med (Mosk); 1991 Jan; 69(1):47-8. PubMed ID: 1673730 [TBL] [Abstract][Full Text] [Related]
8. [Myocardial function and the use of propranolol in ischemic heart disease]. Sidorenko BA; Kasatkina LV; Lupanov VP; Mazaev VP Kardiologiia; 1979 Aug; 19(8):70-3. PubMed ID: 491363 [TBL] [Abstract][Full Text] [Related]
9. [Nonachlasine--a new drug for treatment of ischemic heart disease]. Kaverina NV; Markova GA; Chichkanov GG; Chumburidze VB; Basaeva AI Kardiologiia; 1975 Jul; 15(7):43-8. PubMed ID: 1569 [TBL] [Abstract][Full Text] [Related]
10. [The value of xamoterol in moderate ischemic cardiac insufficiency]. Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115 [TBL] [Abstract][Full Text] [Related]
11. [Hemodynamics and myocardial metabolism in coronary disease during beta receptor stimulation and administration of postassium magnesium aspartate (PMA)]. Kühn P; Probst P Verh Dtsch Ges Kreislaufforsch; 1975; 41():148-51. PubMed ID: 7885 [No Abstract] [Full Text] [Related]
12. [Effects of a partial agonist of beta 1 adrenergic receptors (ICI 118,587) on left ventricular performance and metabolism in coronary disease]. Rousseau MF; Pouleur H; Etienne J; Mengeot P; Cheron P Arch Mal Coeur Vaiss; 1984 Jan; 77(1):76-84. PubMed ID: 6142702 [TBL] [Abstract][Full Text] [Related]
13. Cardiac effects of beta-2 adrenoceptor stimulation with intracoronary procaterol in the absence and presence of regional myocardial ischemia in dogs. Noguchi K; Ojiri Y; Chibana T; Moromizato H; Sakanashi M J Pharmacol Exp Ther; 1991 Nov; 259(2):732-7. PubMed ID: 1682484 [TBL] [Abstract][Full Text] [Related]
14. [Increase in myocardial resistance to ischemia by excluding the heart from the circulation by using a beta-adrenergic receptor block]. Portnoĭ VF; Machulin AV; Dvortsin GF; Shargorodskaia AIa Kardiologiia; 1979 Mar; 19(3):80-4. PubMed ID: 34748 [TBL] [Abstract][Full Text] [Related]
15. Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587. Pouleur H; Rousseau MF; Mengeot P; Veriter C; Vincent MF; Brasseur LA Eur Heart J; 1982 Dec; 3 Suppl D():123-7. PubMed ID: 6130945 [No Abstract] [Full Text] [Related]
16. [Effect of nitroglycerin on left ventricular contraction in ischemic heart disease]. Ekha IaE; Lukha OA; Leĭssoo AR Klin Med (Mosk); 1981 Mar; 59(3):36-40. PubMed ID: 6790816 [No Abstract] [Full Text] [Related]
17. Temporal relationship of contractility and myocardial potassium balance following beta-adrenergic stimulation of the in situ pig heart. Ellingsen O; Vengen OA; Sejersted OM; Ilebekk A Acta Physiol Scand; 1988 Feb; 132(2):241-50. PubMed ID: 2906501 [TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of the inotropic action of nonachlazine]. Kaverina NV; Katsenovich RA; Tkachenko BI; Iunusov ZZ; Ovsiannikov VI Farmakol Toksikol; 1985; 48(1):23-7. PubMed ID: 3979531 [TBL] [Abstract][Full Text] [Related]
19. [Troponin component of the cardiotropic effect of levosimendan on the isolated myocardium from patients with chronic coronary insufficiency]. Afanas'ev SA; Timofeev VIu; Karpov RS Biull Eksp Biol Med; 1999 Oct; 128(10):457-8. PubMed ID: 10599510 [No Abstract] [Full Text] [Related]
20. [Effect of sensit on the course of ischemic heart disease]. Nesvetov VN; Gorshkov VA; Kuliamin VI; Buskin VD Sov Med; 1988; (3):57-61. PubMed ID: 3413552 [No Abstract] [Full Text] [Related] [Next] [New Search]